"Your health and safety are always our top priority. To help you protect yourself and your loved ones, we’ve gathered the most important information and guidance on the coronavirus and COVID-19. Go to our website. You have many ways to get care without leaving the comfort of your home - including an e-visit, phone, video appointments and email. This allows you to still get great care while helping to address the community spread of COVID-19. To book an in-person appointment, or if you’re concerned about your specific health condition, visit our website for your local information on appointments and 24/7 advice."

During the past decade, Kaiser Permanente Dublin conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 4 clinical trials were completed, i.e. on average, 7.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 4 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente Dublin" #1 sponsor was "National Cancer Institute (NCI)" with 27 trials, followed by "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "NRG Oncology" with 10 trials sponsored, "SWOG Cancer Research Network" with 8 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Dublin" #1 collaborator was "National Cancer Institute (NCI)" with 35 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Dublin" are "Lung Non-Squamous Non-Small Cell Carcinoma" (4 trials), "Stage IIIB Lung Cancer AJCC v8" (4 trials), "Stage IV Lung Cancer AJCC v8" (4 trials), "Breast Carcinoma" (3 trials) and "Invasive Breast Carcinoma" (3 trials). Many other conditions were trialed in "Kaiser Permanente Dublin" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente Dublin" are "Drug" (42 trials), "Other" (41 trials), "Biological" (24 trials), "Procedure" (24 trials) and "Radiation" (16 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (20 trials), "Questionnaire Administration" (18 trials), "Biospecimen Collection" (15 trials), "Computed Tomography" (14 trials) and "Nivolumab" (14 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente Dublin" are 50 trials for "All" genders, 7 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente Dublin". undefined are not yet recruiting, 28 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kaiser Permanente Dublin, 3 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente Dublin, 1 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".